Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Clinical guidelines (2015) Determining sensitivity of microorganisms to antimicrobial agents. The interregional association for clinical microbiology and antimicrobial chemotherapy https://biovitrum.ru/files/klinicheskie_rekomendacii_opredeleniya_chuvstvitel_nosti_versiya_2015_02.pdf?ysclid=ln8l2dr7q4647255731. Accessed 23 April 2023
2. Chen Q, Shen Y, Zheng J (2021) A review of cystic fibrosis: basic and clinical aspects. Anim Model Exp Med 4:220–232. https://doi.org/10.1002/ame2.12180
3. Ihssane B, Fatima E, Aboubakr K, Timinouni M, Kaotar N (2023) New alternative therapeutic strategies against Pseudomonas aeruginosa, an opportunistic multi-resistant pathogen with a myriad of virulence factors. J Infect Dev Ctries 17:891–904. https://doi.org/10.3855/jidc.17739
4. Rossi E, La Rosa R, Bartell JA, Marvig RL, Haagensen JAJ, Sommer LM et al (2021) Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis. Nat Rev Microbiol 19:331–342. https://doi.org/10.1038/s41579-020-00477-5
5. Ciuca IM, Dediu M, Popin D, Pop LL, Tamas LA, Pilut CN et al (2022) Antibiotherapy in children with cystic fibrosis: an extensive review. Children (Basel) 9:1258. https://doi.org/10.3390/children9081258